Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when IBIO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsiBio schedules 2026 annual meeting for Oct 14, revises stockholder proposal deadlines
Filed July 17, 2026 · Period ending July 17, 2026 · ~1 min read
Key Changes
-
low
Annual meeting set for Oct 14, 2026 with Sept 1 record date, more than 30 days earlier than prior year's meeting anniversary, triggering accelerated stockholder proposal deadlines.
Item 8.01 verify on EDGAR → -
low
Rule 14a-8 proxy proposals must be received by Aug 1, 2026; non-Rule 14a-8 bylaw proposals by Jul 27, 2026; universal proxy rule director nominations by Aug 15, 2026.
Item 8.01 verify on EDGAR → -
low
Item 5.08 section appears incomplete, containing only a partial sentence with no substantive disclosure about shareholder director nominations.
Item 5.08 verify on EDGAR →
Summary
iBio disclosed routine governance calendar updates, scheduling its 2026 annual stockholder meeting for October 14, 2026, with a September 1 record date. Because this meeting date is more than 30 days earlier than the prior year's meeting anniversary, the company revised its stockholder proposal deadlines: Rule 14a-8 proxy proposals are due August 1, non-Rule 14a-8 bylaw proposals July 27, and universal proxy rule director nominations August 15. These are procedural disclosures with no material impact on operations or strategy.
The filing also contains an incomplete Item 5.08 section that cuts off mid-sentence and provides no information about shareholder director nominations. This appears to be a filing error rather than a substantive disclosure. Retail holders can safely disregard this 8-K as administrative housekeeping.
Section-by-Section Diff
Event · Item 8.01 — Other Events
Item 8.01 — Other Events filed; see Key Changes for terms.
Show 3 minor / wording changes
Added in current filing · verify on EDGAR →
In order for a stockholder proposal, submitted pursuant to Rule 14a-8, to be considered timely for inclusion in the Company’s proxy statement and form of proxy for the 2026 Annual Meeting, such proposal must be received by the Company by August 1, 2026.
Stockholders seeking to include proposals in the company's proxy materials under SEC Rule 14a-8 must submit them by August 1, 2026. This is an accelerated deadline compared to prior disclosures due to the earlier meeting date.
Added in current filing · verify on EDGAR →
To be considered timely, such stockholder proposals must be received by the Company at its principal executive office no later than July 27, 2026, which is the tenth day following public disclosure of the date of the 2026 Annual Meeting via this Current Report on Form 8-K.
Stockholders intending to present proposals at the meeting that are not included in proxy materials must submit them by July 27, 2026, which is ten days after this 8-K disclosure. This deadline applies to proposals submitted under the company's bylaws rather than SEC rules.
Added in current filing · verify on EDGAR →
In addition, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than August 15, 2026, which is 60 days prior to the date of the 2026 Annual Meeting.
Stockholders planning to nominate alternative director candidates and solicit proxies must comply with Rule 14a-19 by August 15, 2026, which is 60 days before the meeting. This deadline applies to proxy contests under the SEC's universal proxy rules.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jul 19, 2026 · How we verify